These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1923 related articles for article (PubMed ID: 31582403)

  • 1. METTL3-mediated m
    Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
    Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3-mediated N
    Zang Y; Tian Z; Wang D; Li Y; Zhang W; Ma C; Liao Z; Gao W; Qian L; Xu X; Jia J; Liu Z
    Oncogene; 2024 Jul; 43(30):2338-2354. PubMed ID: 38879589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Xie JW; Huang XB; Chen QY; Ma YB; Zhao YJ; Liu LC; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Mol Cancer; 2020 Jul; 19(1):114. PubMed ID: 32650804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis.
    Song C; Zhou C
    J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
    Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
    Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-mediated m
    Huo FC; Zhu ZM; Zhu WT; Du QY; Liang J; Mou J
    Oncogene; 2021 Apr; 40(16):2968-2981. PubMed ID: 33758320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Liu Y; Zhai E; Chen J; Qian Y; Zhao R; Ma Y; Liu J; Huang Z; Cai S; Chen J
    Cancer Commun (Lond); 2022 Apr; 42(4):327-344. PubMed ID: 35261206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer.
    Lin JX; Lian NZ; Gao YX; Zheng QL; Yang YH; Ma YB; Xiu ZS; Qiu QZ; Wang HG; Zheng CH; Li P; Xie JW; Lu J; Chen QY; Cao LL; Lin M; Wang JB; Huang CM
    Cell Death Dis; 2022 May; 13(5):463. PubMed ID: 35568711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
    Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
    Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m
    Ren M; Pan H; Zhou X; Yu M; Ji F
    J Transl Med; 2024 Jun; 22(1):584. PubMed ID: 38902717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m
    He H; Wu W; Sun Z; Chai L
    Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.